查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1467781

2024-2032 年按類型、藥物類型、給藥途徑、配銷通路和地區分類的單純皰疹病毒治療市場報告

Herpes Simplex Virus Treatment Market Report by Type, Drug Type, Route of Administration, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球單純皰疹病毒治療市場規模達26億美元。個人對各種 HSV 藥物的認知不斷提高、醫療保健支出增加以及透過線上和線下藥局廣泛獲得 HSV 藥物是推動市場的一些關鍵因素。

單純皰疹病毒（HSV）是一種傳染性病毒感染，透過唾液、精液和陰道分泌物傳播，引起水皰和潰瘍。它在個體中產生單純皰疹病毒 1 (HSV-1) 感染和單純皰疹病毒 2 (HSV-2) 感染。在潰瘍出現之前，它還會引起發燒、身體疼痛、淋巴結腫大、頭痛、刺痛、搔癢或口腔周圍灼熱感。它通常發生在性伴侶感染 HSV 或免疫功能低下的人群中。 HSV 可以透過服用一些抗病毒藥物來治愈，例如阿昔洛韋、泛昔洛韋和伐昔洛韋。也可以透過一些家庭療法來治療，例如熱敷或冷敷、蘆薈、小蘇打或玉米澱粉和水的糊狀物，以及壓碎的大蒜的混合物。 HSV 治療有助於降低病毒傳播的機會並降低爆發的頻率或嚴重程度。

單純皰疹病毒治療市場趨勢：

目前，全球性傳染病（STI）盛行率不斷上升，是支持市場成長的關鍵因素之一。此外，由於全世界個人對性健康的擔憂，對 HSV 治療的需求不斷增加，這也促進了市場的成長。除此之外，由於全球個人對 HSV 感染風險和併發症的認知不斷提高，對 HSV 治療的需求不斷成長，這對市場產生了積極影響。此外，對副作用減少、療效增強的新 HSV 治療方案的需求不斷成長，正在推動市場的成長。除此之外，不斷增加的醫療保健支出以及個人收入水準的上漲，為行業投資者提供了利潤豐厚的成長機會。此外，HSV 藥物透過全球線上和線下藥局的廣泛供應正在推動市場的成長。除此之外，個人對 HSV 治療方案的需求不斷增加，以預防嚴重併發症，如腦炎（腦部感染）或角膜炎（眼部感染），也促進了市場的成長。此外，單純皰疹病毒治療方案的不斷創新和各種藥物的批准正在加強市場的成長。

本報告回答的關鍵問題

  • 全球單純皰疹病毒治療市場有多大？
  • 2024-2032年全球單純皰疹病毒治療市場的預期成長率為何？
  • 推動全球單純皰疹病毒治療市場的關鍵因素是什麼？
  • COVID-19 對全球單純皰疹病毒治療市場有何影響？
  • 根據藥物類型，全球單純皰疹病毒治療市場的詳細情形如何？
  • 根據給藥途徑，全球單純皰疹病毒治療市場的詳細情形如何？
  • 基於配銷通路的全球單純皰疹病毒治療市場的詳細情形如何？
  • 全球單純皰疹病毒治療市場的關鍵地區有哪些？
  • 全球單純皰疹病毒治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球單純皰疹病毒治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 單純皰疹病毒 1 感染
    • 市場走向
    • 市場預測
  • 單純皰疹病毒 2 感染
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按藥物類型

  • 阿昔洛韋
    • 市場走向
    • 市場預測
  • 伐昔洛韋
    • 市場走向
    • 市場預測
  • 泛昔洛韋
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 口服
    • 市場走向
    • 市場預測
  • 可注射
    • 市場走向
    • 市場預測
  • 專題
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 藥局
    • 市場走向
    • 市場預測
  • 零售店
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agenus Inc.
    • Apotex Inc.
    • Avet Pharmaceuticals Inc.
    • Carlsbad Tech
    • EPI Health LLC
    • F. Hoffmann-La Roche Ltd
    • Fresenius SE & Co. KGaA
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals Limited
    • Merck & Co. Inc.
    • Novartis AG
    • Sanofi SA
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: SR112024A5257

The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032. The growing awareness among individuals about various medications of HSV, increasing healthcare expenditure, and wide availability of HSV medications through online and offline pharmacy stores represent some of the key factors driving the market.

Herpes simplex virus (HSV) refers to a contagious viral infection that is spread through saliva, semen, and vaginal secretion and causes blisters and ulcers. It produces herpes simplex virus-1 (HSV-1) infection and herpes simplex virus-2 (HSV-2) infection among individuals. It also causes fever, body aches, swollen lymph nodes, headache, tingling, itching, or burning sensation around the mouth of an individual before the appearance of sores. It usually occurs among people having a sexual partner with HSV or who are immunocompromised. HSV can be cured by consuming some antiviral medications, such as acyclovir, famciclovir, and valacyclovir. It can also be treated through some home remedies, such as a warm or cold compress, aloe vera, a paste of baking soda or cornstarch and water, and a mixture of crushed garlic. HSV treatment can aid in lowering the chance of transmitting the virus and reducing the frequency or severity of outbreaks.

Herpes Simplex Virus Treatment Market Trends:

At present, the rising prevalence of sexually transmitted infections (STIs) among the masses around the world represents one of the key factors supporting the growth of the market. In addition, the increasing demand for HSV treatments due to concerns about sexual health among individuals worldwide is bolstering the growth of the market. Besides this, the growing demand for HSV treatments due to the increasing awareness among individuals about the risks and complications of HSV infection across the globe is positively influencing the market. Moreover, the rising demand for new HSV treatment options with reduced side effects and enhanced effectiveness is propelling the growth of the market. Apart from this, the increasing healthcare expenditure, along with the inflating income level of individuals, is offering lucrative growth opportunities to industry investors. Additionally, the wide availability of HSV medications through online and offline pharmacy stores across the globe is impelling the growth of the market. Besides this, the increasing demand for HSV treatment options to prevent severe complications, such as encephalitis (brain infection) or keratitis (eye infection) among individuals, is contributing to the growth of the market. Furthermore, the rising innovations in HSV treatment options and various drug approvals are strengthening the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global herpes simplex virus treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type, route of administration and distribution channel.

Type Insights:

Herpes Simples Virus-1 Infection

Herpes Simplex Virus-2 Infection

Others

The report has provided a detailed breakup and analysis of the herpes simplex virus treatment market based on the type. This includes herpes simples virus-1 infection, herpes simplex virus-2 infection, and others.

Drug Type Insights:

Acyclovir

Valacyclovir

Famciclovir

Others

A detailed breakup and analysis of the herpes simplex virus treatment market based on the drug type has also been provided in the report. This includes acyclovir, valacyclovir, famciclovir, and others. According to the report, acyclovir accounted for the largest market share.

Route of Administration Insights:

Oral

Injectable

Topical

A detailed breakup and analysis of the herpes simplex virus treatment market based on the route of administration has also been provided in the report. This includes oral, injectable, and topical. According to the report, oral accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacy

Drug Stores

Retail Stores

Online Pharmacy

A detailed breakup and analysis of the herpes simplex virus treatment market based on the distribution channel has also been provided in the report. This includes hospital pharmacy, drug stores, retail stores, and online pharmacy. According to the report, hospital pharmacy accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for herpes simplex virus treatment. Some of the factors driving the North America herpes simplex virus treatment market included the growing prevalence of HSV infection among individuals, increasing number of clinical trials for its treatment, rising awareness about various medications of HSV, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global herpes simplex virus treatment market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Agenus Inc., Apotex Inc., Avet Pharmaceuticals Inc., Carlsbad Tech, EPI Health LLC, F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Merck & Co. Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. How big is the global herpes simplex virus treatment market?
  • 2. What is the expected growth rate of the global herpes simplex virus treatment market during 2024-2032?
  • 3. What are the key factors driving the global herpes simplex virus treatment market?
  • 4. What has been the impact of COVID-19 on the global herpes simplex virus treatment market?
  • 5. What is the breakup of the global herpes simplex virus treatment market based on the drug type?
  • 6. What is the breakup of the global herpes simplex virus treatment market based on the route of administration?
  • 7. What is the breakup of the global herpes simplex virus treatment market based on the distribution channel?
  • 8. What are the key regions in the global herpes simplex virus treatment market?
  • 9. Who are the key players/companies in the global herpes simplex virus treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Herpes Simplex Virus Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Herpes Simples Virus-1 Infection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Herpes Simplex Virus-2 Infection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Acyclovir
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Valacyclovir
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Famciclovir
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injectable
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Drug Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Stores
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Online Pharmacy
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agenus Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Apotex Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Avet Pharmaceuticals Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Carlsbad Tech
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 EPI Health LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 F. Hoffmann-La Roche Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Fresenius SE & Co. KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 GlaxoSmithKline plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Glenmark Pharmaceuticals Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Merck & Co. Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Novartis AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Teva Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Viatris Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials

List of Figures

  • Figure 1: Global: Herpes Simplex Virus Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Herpes Simplex Virus Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Herpes Simplex Virus Treatment Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Herpes Simplex Virus Treatment Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Herpes Simplex Virus Treatment Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Herpes Simplex Virus Treatment Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Herpes Simplex Virus Treatment Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Herpes Simplex Virus Treatment (Herpes Simples Virus-1 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Herpes Simplex Virus Treatment (Herpes Simplex Virus-2 Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Herpes Simplex Virus Treatment (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Herpes Simplex Virus Treatment (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Herpes Simplex Virus Treatment (Acyclovir) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Herpes Simplex Virus Treatment (Acyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Herpes Simplex Virus Treatment (Valacyclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Herpes Simplex Virus Treatment (Famciclovir) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Herpes Simplex Virus Treatment (Famciclovir) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Herpes Simplex Virus Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Herpes Simplex Virus Treatment (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Herpes Simplex Virus Treatment (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Herpes Simplex Virus Treatment (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Herpes Simplex Virus Treatment (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Herpes Simplex Virus Treatment (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Herpes Simplex Virus Treatment (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Herpes Simplex Virus Treatment (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Herpes Simplex Virus Treatment (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Herpes Simplex Virus Treatment (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Herpes Simplex Virus Treatment (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Herpes Simplex Virus Treatment (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Herpes Simplex Virus Treatment (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Herpes Simplex Virus Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Herpes Simplex Virus Treatment Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Herpes Simplex Virus Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Herpes Simplex Virus Treatment Industry: SWOT Analysis
  • Figure 87: Global: Herpes Simplex Virus Treatment Industry: Value Chain Analysis
  • Figure 88: Global: Herpes Simplex Virus Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Herpes Simplex Virus Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Herpes Simplex Virus Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Herpes Simplex Virus Treatment Market: Competitive Structure
  • Table 8: Global: Herpes Simplex Virus Treatment Market: Key Players